Antischistosomal activity of aminoalkanethiols, aminoalkanethiosulfuric acids and the corresponding disulfides

Acta Tropica

Volumn 108, Issue 2-3, 2008, Pages 249-255

  de Oliveira Penido, Marcus Luiz ^a   Zech Coelho, Paulo Marcos ^b,c   de Mello, Rômulo Teixeira ^a   Piló Veloso, Dorila ^a   de Oliveira, Mônica Cristina ^a   Kusel, John Robert ^d   Nelson, David Lee ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Santa Casa de Belo Horizonte   (Brazil)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aminoalkanethiols; Aminoalkanethiosulfates; Aminoalkyl disulfides; In vitro studies; In vivo studies; Nanoemulsion; Schistosoma mansoni; Schistosomicides

Indexed keywords

1 ALKYLAMINO 2 ALKANETHIOL; 2 (N ALKYLAMINO) 1 ALKANETHIOSULFURIC ACID; AMINOALKANETHIOL; AMINOALKANETHIOSULFURIC ACID; AMINOALKYLDISULFIDE; AMINOETHANEPHOSPHOROTHIOIC ACID; AMINOETHANETHIOSULFURIC ACID; AMINOETHYLISOTHIOURONIUM; MERCAPTOETHANAMINE; N ALKYL N [2 ([1 [(ALKYLAMINO)METHYL]ALKYL']DISULFANYL)ALKYL]AMINE; OXAMNIQUINE; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ALCOHOL; FLATWORM; METABOLISM; SULFURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ANTISCHISTOSOMAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG METABOLISM; DRUG RESISTANCE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INTEGUMENT; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMULUM;

ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SULFUR COMPOUNDS;

ANIMALIA; SCHISTOSOMA MANSONI;

EID: 56949104564     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.10.005     Document Type: Article

References (51)

1. Abdulla M.-H., Lim K.-C., Sajid M., McKerrow J.H., and Caffrey C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med. 4 (2007) e14
2. Andrade M.H.G., Freire A.C.T., and Nelson D.L. Pharmacokinetic aspects of tert-butylaminoethyl disulfide. An experimental drug against schistosomiasis in mice. Mem. Inst. Oswaldo Cruz 84 (1989) 95-102
3. Andrade M.H.G., Freire A.C.T., and Nelson D.L. Pharmacokinetic profile of tert-butylaminoethanethiol. Mem. Inst. Oswaldo Cruz 85 (1990) 353-356
4. Araújo N.P., Souza C.P., Passos L.D.J., Simpson A.J.G., Dias-Neto E., Pereira T.R., Ceruti J.R.C., Alencar F.E.C., Dietz R., and Katz N. Susceptibilidade dos agentes quimioterápicos de isolados de S. mansoni oriundos de pacientes tratados com oxamniquina e praziquantel e não curados. Rev. Soc. Bras. Med. Trop. 29 (1996) 467-476
5. Araújo S.C., Mattos A.C.A., Teixeira H.F., Coelho P.M.Z., Nelson D.L., and Oliveira M.C. In vitro efficacy improvement of a novel schistosomicidal drug by incorporation into nanoemulsions. Int. J. Pharm. 337 (2007) 307-315
6. Batzinger R.P., and Bueding E. Mutagenic activities in vitro and in vivo of five antischistosomal compounds. J. Pharmacol. Exp. Ther. 200 (1977) 221-223
7. Bonesso-Sabadini P.I.P., and Dias L.C.S. Altered response of Schistosoma mansoni to oxamniquine and praziquantel. Mem. Inst. Oswaldo Cruz 97 (2002) 381-385
8. Botros S., Sayed H., Amer N., El-Ghannam M., Bennett J.L., and Day T.A. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int. J. Parasitol. 35 (2005) 787-791
9. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Curr. Opin. Chem. Biol. 11 (2007) 433-439
10. Cioli D., Pica-Mattoccia L., and Archer S. Drugs resistance in schistosomes. Parasitol. Today 9 (1993) 162-166
11. Cioli D., Pica-Mattoccia .L., and Archer S. Antischistosomal drugs: past, present and future?. Pharmacol. Ther. 68 (1995) 35-85
12. Coelho P.M.Z., Lima F.C.S., and Nogueira J.A. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from a patient submitted to repeated treatments. Rev. Inst. Med. Trop. São Paulo 39 (1997) 101-106
13. Coelho P.M.Z., Ribeiro F., Mello R.T., Silva F.C.L., and Nogueira-Machado J.A. Activity of oxamniquine at skin, pulmonary and sexual maturation phases on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase. Mem. Inst. Oswaldo Cruz 93 (1998) 267-268
14. Conceição M.J., Argento C.A., and Corrêa A. Study of Schistosoma mansoni isolates with failure of treatment with oxaquimniquine. Mem. Inst. Oswaldo Cruz 95 (2000) 375-380
15. Dias L.C.S., Pedro R.J., Rigo E., and Mafra G.L. Linhagem humana de Schistosoma mansoni resistente a esquistossomicidas. Rev. Saúde Públ. São Paulo 12 (1978) 110
16. Dias L.C.S., Pedro R.J., and Deberaldini E.R. Use of prazinquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of S. mansoni to schistosomal agents. Trans. R. Soc. Trop. Med. Hyg. 76 (1982) 652-659
17. Drescher K.M., Rogers E.J., Bruce J.T., Katz N., Dias L.C.S., and Coles E.C. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents. Mem. Inst. Oswaldo Cruz 88 (1993) 89-95
18. Fallon P.G., and Doenhoff M.J. Drug resistance of Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51 (1994) 83-88
19. Fenwick A., and Webster J.P. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19 (2006) 577-582
20. Guimarães R.X., Tchakerian A., Dias L.C.S., De Almeida F.M.R., Vilela M.P., Cabeça M., and Takeda A.K. Resistência ao hycanthone e oxamniquina em doentes com esquistossomose forma clínica hepato-intestinal. Rev. Ass. Méd. Bras. 25 (1979) 48-50
21. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., Day T.A., and Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high dose of praziquantel. Am. J. Trop. Med. Hyg. 55 (1996) 214-218
22. Ismail M., Botros S., Metwally A., William S., Farghaly A., Tao L.F., Day T.A., and Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
23. Katz N. Experiência com quimioterapia em grande escala no controle da esquistossomose no Brasil. Rev. Inst. Med. Trop. São Paulo 22 (1980) 40-51
24. Katz N., and Coelho P.M.Z. Clinical therapy of schistosomiasis mansoni: The Brazilian contribution. Acta Trop. 108 (2008) 72-78
25. Katz N., Dias E.P., Araújo N., and Souza C.P. Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas. Ver. Soc. Brás. Méd. Trop. 33 (2000) 303-308
26. Keiser J., and Utzinger J. Advances in the discovery and development of novel trematocidal drugs. Exp. Opin. Drug Discov. 2 Suppl. 1 (2007) S9-23
27. King C.H., Dickman K., and Tisch D.J. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365 (2005) 1561-1569
28. Klayman D.L., and Gilmore W.F. The synthesis of N-substituted 2-aminoethanethiosulfuric acids. J. Med. Chem. 7 (1964) 823-824
29. Liu, W.Y., 1981. Síntese de novos ácidos N-alquilaminoalcanotiossulfúricos potencialmente ativos contra S. mansoni e de N-alquilamino-bromoalcanos inéditos. MSc. Thesis. Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil, 179 pp.
30. Liu W.Y., Piló-Veloso D., and Nelson D.L. A síntese de ácidos N-alquilaminoalcanotiossulfúricos potencialmente ativos contra esquistossomose mansoni. Resumos do XVI Cong. (1984), Latinoamer. Quim., Rio de Janeiro, RJ Brazil 561
31. Moreira L.S.A., Nelson D.L., and Piló-Veloso D. Synthesis of 2-(alkylamino)-1-phenylethane-1-thiosulfuric acids, potential schistosomicides. Quim. Nova 23 (2000) 447-452
32. Moreira L.S.A., Piló-Veloso D., de Mello R.T., Coelho P.M.Z., and Nelson D.L. A study of the activity of 2-alkylamino-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model. Trans. R. Soc. Trop. Med. Hyg. 101 4 (2007) 385-390
33. Nelson D.L., and Pellegrino J. Experimental chemotherapy of schistosomiasis mansoni. XI. Active derivatives of aminoethanethiols. Rev. Med. Trop. São Paulo 18 (1976) 264-267
34. Nelson D.L., and Pellegrino J. Experimental chemotherapy of schistosomiasis. XII. Active derivatives of aminoethanethiosulfuric acids. Rev. Inst. Med. Trop. São Paulo 18 (1976) 365-370
35. Nelson D.L., and Pellegrino J. Experimental chemotherapy of schistosomiasis. XIV. Active derivatives of aminoethanephosphorothioate, disulfide, and isothiourea. Rev. Inst. Med. Trop. São Paulo 18 (1976) 443-449
36. o Reunião Anual da Sociedade Brasileira para o Progresso da Ciência, São Paulo, SP, p. 455.
37. Pellegrino J., and Faria J. The oogram method for the screening of drugs in schistosomiasis mansoni. Am. J. Trop. Med. Hyg. 14 (1965) 363-369
38. Pellegrino J., and Siqueira A.F. Técnica de perfusão para colheita de Schistosoma mansoni em cobaias experimentalmente infestadas. Rev. Brasil. Malariol. Doenças Trop. 8 (1968) 589-597
39. Penido M.L.O., Nelson D.L., and Piló-Veloso D. Synthesis of potential schistosomicides: new 2-(N-Alkylamino)-1-octanethiosulfuric acids. J. Braz. Chem. Soc. 1 (1990) 35-40
40. Penido M.L.O., Nelson D.L., and Piló-Veloso D. Schistosomicidal activity of alkylaminooctanethiosulfuric Acids. Mem. Inst. Oswaldo Cruz 89 (1994) 595-602
41. Penido M.L.O., Nelson D.L., Vieira L.Q., Watson D.G., and Kusel J.R. Metabolism by Schistosoma mansoni of a new schistosomicide: 2-[1-methylpropyl)amino]-1-octanethiosulphuric acid. Parasitology 111 (1995) 177-185
42. Penido M.L.O., Coelho P.M.Z., and Nelson D.L. Efficacy of a new schistosomicidal agent 2-[1-methylpropil]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate. Mem. Inst. Oswaldo Cruz 94 (1999) 811-813
43. Prado, M.A.F., 1983. Síntese de cloridratos de N-alquil-2-mercapto-1-pentilamina e de 2,2-ditiobis(N-alquil-1-pentilamina) potencialmente esquistossomicidas. Masters Thesis. Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil, 116 pp.
44. Ribeiro-dos-Santos G., Verjovski-Almeida S., and Leite L.C.C. Schistosomiasis-a century searching for chemotherapeutic drugs. Parasitol. Res. 99 (2006) 505-521
45. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., and Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 14 (2008) 407-412
46. Serra, A.A., 1983. Síntese de 1-alquilamino-2-heptanotióis e respectivos dissulfetos, potencialmente ativos contra S. mansoni. Masters Thesis. Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil, 156 pp.
47. Steinmann P., Keiser J., Bos R., Tanner M., and Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6 (2006) 411-425
48. Stelma F.F., Talla A., Sow S., Kongs A., Nang M., Polman K., Deelder A.M., and Gryssels B. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53 (1995) 167-170
49. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W.N., Nagelkerke N.J.D., Habbema J.D.F., and Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86 (2003) 125-139
50. Vieira Filho S.A., Nelson D.L., and Piló-Veloso D. Synthesis of new n-alkyl-2-mercapto-1-octylamines and respective disulfides. An. Acad. Bras. Ciên. 58 (1986) 547-551
51. Xiao S.-H.J., Keiser J., Chollet J., Utzinger J., Dong Y., Endriss Y., Vennerstrom J.L., and Tanner M. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob. Agents Chemother. 51 (2007) 1440-1445